These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 45260)

  • 1. [Behavior of cardiac output, plasma volume, plasma renin activity and aldosterone secretion in patients with essential hypertension treated with beta-blocking agents and diuretics].
    Salerno L; Licata G; Sparacino V; Custro N; Indovina I
    Clin Ter; 1979 Aug; 90(3):223-32. PubMed ID: 45260
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC
    Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].
    Bühler FR
    Schweiz Med Wochenschr; 1974 Jul; 104(29):1013-22. PubMed ID: 4153738
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenergic blockade in diuretic-treated patients with essential hypertension.
    Bravo EL; Tarazi RC; Dustan HP
    N Engl J Med; 1975 Jan; 292(2):66-70. PubMed ID: 234005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic consequences of intrinsic sympathomimetic activity in relation to changes in plasma renin activity and noradrenaline during beta-blocker therapy for hypertension.
    Man in't Veld AJ; Schalekamp MA
    Postgrad Med J; 1983; 59 Suppl 3(689):140-58. PubMed ID: 6139800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Beta-blocking agents alone or combined with diuretics or alpha-adrenolytics in the treatment of essential arterial hypertension].
    Minutillo S; Lupinc V; D'Agnolo B
    Minerva Med; 1979 Dec; 70(57):3919-24. PubMed ID: 43488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of beta-receptor blocking agents in the treatment of arterial hypertension].
    Hilden T; Ibsen H
    Ugeskr Laeger; 1973 May; 135(20):961-4. PubMed ID: 4148294
    [No Abstract]   [Full Text] [Related]  

  • 9. [Blood volume, plasma renin activity and plasma aldosterone concentration in patients with essential hypertension who were treated for more than ten years (author's transl)].
    Nakamura Y
    Nihon Naika Gakkai Zasshi; 1980 Jun; 69(6):714-22. PubMed ID: 6997417
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurement of plasma renin activity, blood volume and exchangeable sodium: an aid in the orientation of treatment of essential arterial hypertension].
    Olmer M; Ducros J; Grandvuillemin M; Salvadori JM
    Sem Hop; 1977 May; 53(20):1147-53. PubMed ID: 20666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers and plasma renin activity in hypertension.
    Stokes GS; Weber MA; Thornell IR
    Br Med J; 1974 Jan; 1(5897):60-2. PubMed ID: 4149613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of plasma renin activity and aldosterone levels with hemodynamic functions in essential hypertension.
    London GM; Safar ME; Weiss YA; Corvol PL; Menard JE; Simon AC; Milliez PL
    Arch Intern Med; 1977 Aug; 137(8):1042-7. PubMed ID: 327963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of renin after betablocking diuretic and vasodilator treatment in essential hypertension (author's transl)].
    Lombardo M; Fusco M; Valente D
    G Ital Cardiol; 1979; 9(12):1363-70. PubMed ID: 45015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenergic blocking therapy in hypertension: selection of patients.
    Frohlich ED; Tarazi RC; Dustan HP
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):151-6. PubMed ID: 4395481
    [No Abstract]   [Full Text] [Related]  

  • 15. [Role of renin profile and age in the choice of the therapeutic approach of arterial hypertension (author's transl)].
    Glorioso N; Madeddu P; Dessì Fulgheri P; Sanna G; Fiori C; Dettori S; Cocco F; Rappelli A
    G Ital Cardiol; 1981; 11(12):2117-25. PubMed ID: 6125451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive therapy with diuretics and beta-blockers at fixed dosage: comparison between the combinations labetalol plus chlorthalidone and atenolol plus chlorthalidone.
    Roja M; Cumetti C; Vergani A; Montanari C; De Cristofaro A
    Drugs Exp Clin Res; 1985; 11(12):851-60. PubMed ID: 2873012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug combinations in the treatment of primary arterial hypertension].
    Angelino PF
    Minerva Med; 1975 Feb; 66(13):602-11. PubMed ID: 1113910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blocking agents in the treatment of hypertension.
    Stumpe KO; Kolloch RE
    Compr Ther; 1977 May; 3(5):55-65. PubMed ID: 16724
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
    Jaeger P; Brunner HR; Turini GA; Jéquier E; Ferguson RK; Gavras H
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1707-9. PubMed ID: 715407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal effects of nitrendipine monotherapy in essential hypertension.
    Thananopavarn C; Golub MS; Eggena P; Barrett JD; Sambhi MP
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1032-6. PubMed ID: 6085362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.